Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Park Ha Biological Technology Co EV-to-FCF?
Park Ha Biological Technology CoBYAH -13.77%20 EV-to-FCF is 264.75 as of Jul. 14, 2026, which is 62% below its 10-year median of 694.48. GuruFocus rates BYAH with a GF Score™ of 20/100. The stock has 2 warning signs investors should review. Among 1,188 Consumer Packaged Goods companies, Park Ha Biological Technology Co ranks worse than 94.61% on this metric.
The historical rank and industry rank for Park Ha Biological Technology Co's EV-to-FCF or its related term are showing as below:
BYAH'
s EV-to-FCF Range Over the Past 10 Years
Min: 10.72 Med: 694.48 Max: 1215.93
Current: 264.75
During the past 5 years, the highest EV-to-FCF of Park Ha Biological Technology Co was 1215.93. The lowest was 10.72. And the median was 694.48.
BYAH's EV-to-FCF is ranked worse than 94.61% of 1188
companies
in the Consumer Packaged Goods industry
Industry Median: 15.85
vs BYAH: 264.75
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Park Ha Biological Technology Co (NAS:BYAH) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Park Ha Biological Technology Co's PE Ratio (TTM) for today is calculated as:
Park Ha Biological Technology Co's share price for today is $0.404.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Park Ha Biological Technology Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Oct. 2025 was $-43.685.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Park Ha Biological Technology Co EV-to-FCF Related Terms
Park Ha Biological Technology Co EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Household & Personal Products subindustry, Park Ha Biological Technology Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Park Ha Biological Technology Co EV-to-FCF vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Park Ha Biological Technology Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Park Ha Biological Technology Co's EV-to-FCF falls into.
Park Ha Biological Technology Co's current Enterprise Value is $-1.06 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Park Ha Biological Technology Co's Free Cash Flow for the trailing twelve months (TTM) ended in Oct. 2025 was $-0.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Park Ha Biological Technology Co (BYAH) has a EV-to-FCF of 264.75 as of Jul. 14, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Park Ha Biological Technology Co and its competitors. This is 62% below median its historical median of 694.48. Over the past decade, Park Ha Biological Technology Co's EV-to-FCF has ranged from 10.72 to 1,215.93. According to the industry distribution chart, Park Ha Biological Technology Co ranks #1124 out of 1188 companies in the Consumer Packaged Goods industry, placing it in the top 94.6%.
Is Park Ha Biological Technology Co's EV-to-FCF too high?
Park Ha Biological Technology Co's current EV-to-FCF of 264.75 is 62% below median its 10-year median of 694.48. Over the past 10 years, this metric has ranged from a low of 10.72 to a high of 1,215.93. The Consumer Packaged Goods industry median EV-to-FCF is 15.85. Park Ha Biological Technology Co's value of 264.75 is 1570.3% above this industry median. Based on the distribution chart, Park Ha Biological Technology Co ranks #1124 out of 1188 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Park Ha Biological Technology Co has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Park Ha Biological Technology Co's EV-to-FCF compare to NASO and TANH?
According to the Consumer Packaged Goods industry distribution chart, Park Ha Biological Technology Co ranks #1124 out of 1188 companies for EV-to-FCF. This places Park Ha Biological Technology Co in the lower half of its industry. The industry median EV-to-FCF is 15.85. Park Ha Biological Technology Co's value of 264.75 is 1570.3% above this benchmark. Historically, Park Ha Biological Technology Co's own EV-to-FCF has ranged from 10.72 to 1,215.93 over the past decade. While the company's 10-year median is 694.48 vs. the industry median of 15.85, Park Ha Biological Technology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Consumer Packaged Goods company?
The median EV-to-FCF among Consumer Packaged Goods companies is 15.85, based on 1,188 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Park Ha Biological Technology Co's current EV-to-FCF of 264.75 is 1570.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Park Ha Biological Technology Co and its competitors. For the Consumer Packaged Goods industry, the median EV-to-FCF is 15.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Park Ha Biological Technology Co's current EV-to-FCF is 264.75, which is 62% below median its own 10-year median of 694.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Park Ha Biological Technology Co stock overvalued right now?
Park Ha Biological Technology Co (BYAH) has a current EV-to-FCF of 264.75. The current EV-to-FCF is 264.75, which is 62% below median its 10-year median of 694.48 and 1570.3% above the Consumer Packaged Goods industry median of 15.85. Park Ha Biological Technology Co's overall GF Score™ is 20/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Park Ha Biological Technology Co (BYAH), the current EV-to-FCF is 264.75 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Park Ha Biological Technology Co Business Description
Park Ha Biological Technology Co Ltd is engaged in developing its private skincare label, direct skincare products sales, and franchise alliances promotions. Its Park Ha brand focuses on providing solutions for problematic skin. The company's Operating Subsidiaries provide skincare and cosmetic products under its brand, Park Ha, in China. Its Operating Subsidiaries develop its proprietary beauty products and offer complementary after-sales beauty services in its physical stores.
20GF Score
Get the complete analysis for BYAH
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BYAH has been successfully added to your 
